Journal articleCancer2025
Long-term outcomes of GemCap for pancreatic ductal adenocarcinoma: GemCap proves to be a standard option for patients not eligible for mFOLFIRINOX.
- Journal
- Cancer
- Published
- 1 July 2025
- Citations
- 0
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try